Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$947000.0.

  • Biofrontera's Change in Receivables fell 16745.01% to -$947000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 26216.45%. This contributed to the annual value of $315000.0 for FY2024, which is 7949.22% down from last year.
  • As of Q3 2025, Biofrontera's Change in Receivables stood at -$947000.0, which was down 16745.01% from -$88000.0 recorded in Q2 2025.
  • Biofrontera's 5-year Change in Receivables high stood at $2.2 million for Q4 2022, and its period low was -$3.1 million during Q2 2022.
  • In the last 5 years, Biofrontera's Change in Receivables had a median value of $10000.0 in 2021 and averaged $8842.1.
  • As far as peak fluctuations go, Biofrontera's Change in Receivables plummeted by 3090000.0% in 2022, and later skyrocketed by 46767.9% in 2023.
  • Quarter analysis of 5 years shows Biofrontera's Change in Receivables stood at $1.8 million in 2021, then grew by 19.7% to $2.2 million in 2022, then tumbled by 38.93% to $1.3 million in 2023, then tumbled by 63.06% to $492000.0 in 2024, then plummeted by 292.48% to -$947000.0 in 2025.
  • Its Change in Receivables was -$947000.0 in Q3 2025, compared to -$88000.0 in Q2 2025 and -$1.3 million in Q1 2025.